Surgery Partners, Inc. (SGRY)
USD 19.88
(-5.47%)
USD 19.88
(-5.47%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 75.2 Million USD | 5.32% |
| 2022 | 71.4 Million USD | 16.86% |
| 2021 | 61.1 Million USD | 8.33% |
| 2020 | 56.4 Million USD | 21.81% |
| 2019 | 46.3 Million USD | 6.77% |
| 2018 | 43.36 Million USD | -3.53% |
| 2017 | 44.95 Million USD | 56.2% |
| 2016 | 28.77 Million USD | 12.45% |
| 2015 | 25.59 Million USD | 8.02% |
| 2014 | 23.69 Million USD | 418.65% |
| 2013 | 4.56 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 77 Million USD | 2.39% |
| 2024 Q2 | 80.9 Million USD | 5.06% |
| 2023 Q2 | 70.3 Million USD | -2.09% |
| 2023 Q1 | 71.8 Million USD | 0.56% |
| 2023 Q3 | 69.4 Million USD | -1.28% |
| 2023 FY | 75.2 Million USD | 5.32% |
| 2023 Q4 | 75.2 Million USD | 8.36% |
| 2022 Q4 | 71.4 Million USD | 4.08% |
| 2022 FY | 71.4 Million USD | 16.86% |
| 2022 Q1 | 62.9 Million USD | 2.95% |
| 2022 Q2 | 64 Million USD | 1.75% |
| 2022 Q3 | 68.6 Million USD | 7.19% |
| 2021 Q2 | 57.3 Million USD | 2.14% |
| 2021 Q1 | 56.1 Million USD | -0.53% |
| 2021 FY | 61.1 Million USD | 8.33% |
| 2021 Q4 | 61.1 Million USD | 3.04% |
| 2021 Q3 | 59.3 Million USD | 3.49% |
| 2020 FY | 56.4 Million USD | 21.81% |
| 2020 Q3 | 50.9 Million USD | 3.88% |
| 2020 Q4 | 56.4 Million USD | 10.81% |
| 2020 Q2 | 49 Million USD | 0.0% |
| 2020 Q1 | 49 Million USD | 5.83% |
| 2019 Q4 | 46.3 Million USD | 4.28% |
| 2019 FY | 46.3 Million USD | 6.77% |
| 2019 Q3 | 44.4 Million USD | 0.91% |
| 2019 Q2 | 44 Million USD | 0.46% |
| 2019 Q1 | 43.8 Million USD | 1.01% |
| 2018 Q4 | 43.36 Million USD | -2.25% |
| 2018 FY | 43.36 Million USD | -3.53% |
| 2018 Q1 | 48.1 Million USD | 7.01% |
| 2018 Q2 | 45.7 Million USD | -4.99% |
| 2018 Q3 | 44.36 Million USD | -2.93% |
| 2017 Q3 | 44.52 Million USD | 50.01% |
| 2017 Q4 | 44.95 Million USD | 0.96% |
| 2017 FY | 44.95 Million USD | 56.2% |
| 2017 Q1 | 29.34 Million USD | 1.97% |
| 2017 Q2 | 29.68 Million USD | 1.15% |
| 2016 Q3 | 26.86 Million USD | 3.61% |
| 2016 FY | 28.77 Million USD | 12.45% |
| 2016 Q4 | 28.77 Million USD | 7.11% |
| 2016 Q2 | 25.93 Million USD | -2.34% |
| 2016 Q1 | 26.55 Million USD | 3.76% |
| 2015 Q4 | 25.59 Million USD | 3.41% |
| 2015 Q2 | 24.23 Million USD | -0.57% |
| 2015 FY | 25.59 Million USD | 8.02% |
| 2015 Q3 | 24.74 Million USD | 2.1% |
| 2015 Q1 | 24.37 Million USD | 2.9% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | 23.69 Million USD | 418.65% |
| 2014 Q4 | 23.69 Million USD | 0.0% |
| 2013 FY | 4.56 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 5.3 Million USD | -1318.868% |
| Addus HomeCare Corporation | - USD | -Infinity% |
| AirSculpt Technologies, Inc. | - USD | -Infinity% |
| Amedisys, Inc. | - USD | -Infinity% |
| American Oncology Network, Inc. | 44.56 Million USD | -68.727% |
| Astrana Health, Inc. | - USD | -Infinity% |
| Aveanna Healthcare Holdings Inc. | - USD | -Infinity% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 20.94 Million USD | -259.036% |
| Cryo-Cell International, Inc. | 768.87 Thousand USD | -9680.498% |
| Cross Country Healthcare, Inc. | - USD | -Infinity% |
| COMPASS Pathways plc | 1.00 USD | -7519999900.0% |
| DocGo Inc. | 1.00 USD | -7519999900.0% |
| The Ensign Group, Inc. | - USD | -Infinity% |
| Healthcare Services Group, Inc. | 18.47 Million USD | -306.948% |
| InnovAge Holding Corp. | -3.32 Million USD | 2362.335% |
| Assure Holdings Corp. | 1.00 USD | -7519999900.0% |
| The Joint Corp. | - USD | -Infinity% |
| LifeStance Health Group, Inc. | 1.00 USD | -7519999900.0% |
| Mobile-health Network Solutions Class A Ordinary Shares | 163.99 Thousand USD | -45755.616% |
| ModivCare Inc. | - USD | -Infinity% |
| NewGenIvf Group Limited | 126.26 Thousand USD | -59457.752% |
| Novo Integrated Sciences, Inc. | 1.1 Million USD | -6693.239% |
| Option Care Health, Inc. | 274 Million USD | 72.555% |
| P3 Health Partners Inc. | - USD | -Infinity% |
| P3 Health Partners Inc. | - USD | -Infinity% |
| The Pennant Group, Inc. | - USD | -Infinity% |
| Syra Health Corp. Class A Common Stock | 1.00 USD | -7519999900.0% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 13.67 Million USD | -449.788% |
| The Oncology Institute, Inc. | 13.67 Million USD | -449.788% |